$ANIK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Anika Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Anika Therapeutics, Inc.. Get notifications about new insider transactions in Anika Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28 2021 | ANIK | Anika Therapeutics ... | Blanchard Cheryl R | President, CEO, Dir ... | Option Exercise | M | 0.00 | 24,575 | 0 | 49,151 | |
| Apr 28 2021 | ANIK | Anika Therapeutics ... | Blanchard Cheryl R | President, CEO, Dir ... | Buy | M | 0.00 | 24,575 | 0 | 34,478 | 9.9 K to 34.5 K (+248.16 %) |
| Mar 11 2021 | ANIK | Anika Therapeutics ... | Loerop James | EVP Business Develo ... | Option Exercise | A | 37.40 | 16,802 | 628,395 | 16,802 | |
| Mar 11 2021 | ANIK | Anika Therapeutics ... | Loerop James | EVP Business Develo ... | Option Exercise | A | 0.00 | 6,705 | 0 | 6,705 | |
| Mar 11 2021 | ANIK | Anika Therapeutics ... | Levitz Michael L | EVP, CFO, Treasurer | Option Exercise | A | 37.40 | 33,363 | 1,247,776 | 33,363 | |
| Mar 11 2021 | ANIK | Anika Therapeutics ... | Levitz Michael L | EVP, CFO, Treasurer | Option Exercise | A | 0.00 | 13,315 | 0 | 13,315 | |
| Mar 11 2021 | ANIK | Anika Therapeutics ... | Finnerty Thomas | EVP Human Resources | Option Exercise | A | 37.40 | 19,158 | 716,509 | 19,158 | |
| Mar 11 2021 | ANIK | Anika Therapeutics ... | Finnerty Thomas | EVP Human Resources | Option Exercise | A | 0.00 | 7,645 | 0 | 7,645 | |
| Mar 11 2021 | ANIK | Anika Therapeutics ... | Colleran David | EVP, General Counse ... | Option Exercise | A | 37.40 | 27,681 | 1,035,269 | 27,681 | |
| Mar 11 2021 | ANIK | Anika Therapeutics ... | Colleran David | EVP, General Counse ... | Option Exercise | A | 0.00 | 11,047 | 0 | 11,047 | |
| Mar 11 2021 | ANIK | Anika Therapeutics ... | Blanchard Cheryl R | President, CEO, Dir ... | Option Exercise | A | 37.40 | 108,398 | 4,054,085 | 108,398 | |
| Mar 11 2021 | ANIK | Anika Therapeutics ... | Blanchard Cheryl R | President, CEO, Dir ... | Option Exercise | A | 0.00 | 43,259 | 0 | 43,259 | |
| Mar 08 2021 | ANIK | Anika Therapeutics ... | Colleran David | EVP, General Counse ... | Option Exercise | M | 0.00 | 2,500 | 0 | 5,000 | |
| Mar 08 2021 | ANIK | Anika Therapeutics ... | Colleran David | EVP, General Counse ... | Buy | M | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Nov 12 2020 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Sell | S | 36.77 | 3,446 | 126,709 | 9,953 | 13.4 K to 10 K (-25.72 %) |
| Sep 08 2020 | ANIK | Anika Therapeutics ... | Richard Stephen | Director | Grant | A | 0.00 | 9,310 | 0 | 9,310 | 0 to 9.3 K |
| Sep 08 2020 | ANIK | Anika Therapeutics ... | HENNEMAN JOHN B III | Director | Grant | A | 0.00 | 9,310 | 0 | 9,310 | 0 to 9.3 K |
| Aug 12 2020 | ANIK | Anika Therapeutics ... | Levitz Michael L | EVP, CFO, Treasurer | Option Exercise | A | 34.55 | 57,145 | 1,974,360 | 57,145 | |
| Aug 12 2020 | ANIK | Anika Therapeutics ... | Levitz Michael L | EVP, CFO, Treasurer | Option Exercise | A | 0.00 | 11,577 | 0 | 11,577 | |
| Jul 10 2020 | ANIK | Anika Therapeutics ... | Loerop James | EVP Business Develo ... | Sell | S | 35.15 | 1,244 | 43,727 | 1,756 | 3 K to 1.8 K (-41.47 %) |
| Jul 10 2020 | ANIK | Anika Therapeutics ... | Loerop James | EVP Business Develo ... | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Apr 28 2020 | ANIK | Anika Therapeutics ... | Blanchard Cheryl R | President, CEO, Dir ... | Option Exercise | A | 33.40 | 104,638 | 3,494,909 | 104,638 | |
| Apr 28 2020 | ANIK | Anika Therapeutics ... | Blanchard Cheryl R | President, CEO, Dir ... | Option Exercise | A | 0.00 | 73,726 | 0 | 73,726 | |
| Apr 28 2020 | ANIK | Anika Therapeutics ... | Blanchard Cheryl R | President, CEO, Dir ... | Payment of Exercise | F | 33.40 | 1,794 | 59,920 | 9,903 | 11.7 K to 9.9 K (-15.34 %) |
| Apr 28 2020 | ANIK | Anika Therapeutics ... | Blanchard Cheryl R | President, CEO, Dir ... | Buy | M | 0.00 | 4,231 | 0 | 11,697 | 7.5 K to 11.7 K (+56.67 %) |
| Mar 06 2020 | ANIK | Anika Therapeutics ... | Colleran David | EVP, General Counse ... | Option Exercise | A | 43.06 | 35,000 | 1,507,100 | 35,000 | |
| Mar 06 2020 | ANIK | Anika Therapeutics ... | Colleran David | EVP, General Counse ... | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
| Feb 27 2020 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Sell | S | 42.68 | 2,700 | 115,236 | 13,399 | 16.1 K to 13.4 K (-16.77 %) |
| Feb 27 2020 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Grant | A | 0.00 | 4,107 | 0 | 16,099 | 12 K to 16.1 K (+34.25 %) |
| Feb 27 2020 | ANIK | Anika Therapeutics ... | Finnerty Thomas | Chief Human Resourc ... | Option Exercise | A | 0.00 | 8,500 | 0 | 8,500 | |
| Feb 27 2020 | ANIK | Anika Therapeutics ... | Finnerty Thomas | Chief Human Resourc ... | Payment of Exercise | F | 42.25 | 881 | 37,222 | 8,247 | 9.1 K to 8.2 K (-9.65 %) |
| Feb 27 2020 | ANIK | Anika Therapeutics ... | Finnerty Thomas | Chief Human Resourc ... | Grant | A | 0.00 | 3,000 | 0 | 9,128 | 6.1 K to 9.1 K (+48.96 %) |
| Feb 27 2020 | ANIK | Anika Therapeutics ... | Loerop James | EVP Business Develo ... | Option Exercise | A | 0.00 | 4,700 | 0 | 4,700 | |
| Feb 27 2020 | ANIK | Anika Therapeutics ... | VOGT SUSAN L N | Director | Grant | A | 0.00 | 4,107 | 0 | 11,652 | 7.5 K to 11.7 K (+54.43 %) |
| Feb 27 2020 | ANIK | Anika Therapeutics ... | Larsen Glenn R. | Director | Grant | A | 0.00 | 4,107 | 0 | 11,697 | 7.6 K to 11.7 K (+54.11 %) |
| Feb 27 2020 | ANIK | Anika Therapeutics ... | Bower Joseph L. | Director | Grant | A | 0.00 | 4,107 | 0 | 17,117 | 13 K to 17.1 K (+31.57 %) |
| Feb 27 2020 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 0.00 | 11,700 | 0 | 11,700 | |
| Feb 27 2020 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Payment of Exercise | F | 42.25 | 881 | 37,222 | 49,281 | 50.2 K to 49.3 K (-1.76 %) |
| Feb 27 2020 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Grant | A | 0.00 | 3,000 | 0 | 50,162 | 47.2 K to 50.2 K (+6.36 %) |
| Feb 27 2020 | ANIK | Anika Therapeutics ... | Blanchard Cheryl R | Director | Option Exercise | A | 0.00 | 4,231 | 0 | 4,231 | |
| Feb 27 2020 | ANIK | Anika Therapeutics ... | Thompson Jeffery S | Director | Grant | A | 0.00 | 4,107 | 0 | 10,949 | 6.8 K to 10.9 K (+60.03 %) |
| Feb 06 2020 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Payment of Exercise | F | 40.59 | 579 | 23,502 | 47,162 | 47.7 K to 47.2 K (-1.21 %) |
| Nov 29 2019 | ANIK | Anika Therapeutics ... | Bower Joseph L. | Director | Gift | G | 0.00 | 30,000 | 0 | 13,010 | 43 K to 13 K (-69.75 %) |
| Nov 08 2019 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | M | 6.36 | 35,000 | 222,600 | 0 | |
| Nov 08 2019 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Sell | S | 59.71 | 20,000 | 1,194,200 | 47,741 | 67.7 K to 47.7 K (-29.52 %) |
| Nov 08 2019 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Payment of Exercise | F | 60.48 | 3,681 | 222,627 | 67,741 | 71.4 K to 67.7 K (-5.15 %) |
| Nov 08 2019 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Buy | M | 6.36 | 35,000 | 222,600 | 71,422 | 36.4 K to 71.4 K (+96.10 %) |
| Nov 01 2019 | ANIK | Anika Therapeutics ... | Finnerty Thomas | EVP Human Resources | Payment of Exercise | F | 69.67 | 672 | 46,818 | 6,128 | 6.8 K to 6.1 K (-9.88 %) |
| Aug 30 2019 | ANIK | Anika Therapeutics ... | Larsen Glenn R. | Director | Sell | S | 57.21 | 4,355 | 249,150 | 7,590 | 11.9 K to 7.6 K (-36.46 %) |
| Aug 22 2019 | ANIK | Anika Therapeutics ... | Bower Joseph L. | Director | Sell | S | 55.57 | 1,994 | 110,807 | 43,010 | 45 K to 43 K (-4.43 %) |
| Aug 12 2019 | ANIK | Anika Therapeutics ... | Thompson Jeffery S | Director | Sell | S | 56.66 | 4,843 | 274,404 | 6,842 | 11.7 K to 6.8 K (-41.45 %) |
| Jul 30 2019 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Sell | S | 55.44 | 3,000 | 166,320 | 11,992 | 15 K to 12 K (-20.01 %) |
| Jul 30 2019 | ANIK | Anika Therapeutics ... | Darling Joseph G | President and CEO; ... | Payment of Exercise | F | 55.85 | 2,147 | 119,910 | 20,289 | 22.4 K to 20.3 K (-9.57 %) |
| Jul 09 2019 | ANIK | Anika Therapeutics ... | Loerop James | EVP Business Develo ... | Option Exercise | A | 40.67 | 27,000 | 1,098,090 | 27,000 | |
| Jul 09 2019 | ANIK | Anika Therapeutics ... | Loerop James | EVP Business Develo ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Mar 01 2019 | ANIK | Anika Therapeutics ... | Darling Joseph G | President and CEO; ... | Buy | P | 33.20 | 1,000 | 33,200 | 22,436 | 21.4 K to 22.4 K (+4.67 %) |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | VOGT SUSAN L N | Director | Grant | A | 0.00 | 3,842 | 0 | 7,545 | 3.7 K to 7.5 K (+103.75 %) |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | Thompson Jeffery S | Director | Grant | A | 0.00 | 3,842 | 0 | 11,685 | 7.8 K to 11.7 K (+48.99 %) |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | Larsen Glenn R. | Director | Grant | A | 0.00 | 3,842 | 0 | 11,945 | 8.1 K to 11.9 K (+47.41 %) |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Sell | S | 33.06 | 4,000 | 132,240 | 14,992 | 19 K to 15 K (-21.06 %) |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Grant | A | 0.00 | 3,842 | 0 | 18,992 | 15.2 K to 19 K (+25.36 %) |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | Hague Richard | Chief Commercial Of ... | Option Exercise | A | 61.47 | 3,777 | 232,172 | 3,777 | |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | Hague Richard | Chief Commercial Of ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | Finnerty Thomas | Chief Human Resourc ... | Option Exercise | A | 61.47 | 2,873 | 176,603 | 2,873 | |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | Finnerty Thomas | Chief Human Resourc ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | Darling Joseph G | President and CEO; ... | Option Exercise | A | 61.47 | 7,609 | 467,725 | 7,609 | |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | Darling Joseph G | President and CEO; ... | Option Exercise | A | 0.00 | 63,000 | 0 | 63,000 | |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 61.47 | 7,609 | 467,725 | 7,609 | |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Grant | A | 0.00 | 3,842 | 0 | 45,004 | 41.2 K to 45 K (+9.33 %) |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | Blanchard Cheryl R | Director | Grant | A | 0.00 | 3,842 | 0 | 7,466 | 3.6 K to 7.5 K (+106.02 %) |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | Ahn Edward S. | Chief Tech & Strate ... | Option Exercise | A | 61.47 | 5,625 | 345,769 | 5,625 | |
| Feb 28 2019 | ANIK | Anika Therapeutics ... | Ahn Edward S. | Chief Tech & Strate ... | Option Exercise | A | 0.00 | 4,500 | 0 | 4,500 | |
| Feb 06 2019 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Payment of Exercise | F | 38.10 | 607 | 23,127 | 36,422 | 37 K to 36.4 K (-1.64 %) |
| Feb 06 2019 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Payment of Exercise | F | 37.97 | 579 | 21,985 | 37,029 | 37.6 K to 37 K (-1.54 %) |
| Feb 06 2019 | ANIK | Anika Therapeutics ... | Ahn Edward S. | Chief Tech & Strate ... | Payment of Exercise | F | 38.10 | 685 | 26,099 | 6,575 | 7.3 K to 6.6 K (-9.44 %) |
| Feb 06 2019 | ANIK | Anika Therapeutics ... | Hague Richard | Chief Commercial Of ... | Payment of Exercise | F | 38.10 | 685 | 26,099 | 21,419 | 22.1 K to 21.4 K (-3.10 %) |
| Oct 30 2018 | ANIK | Anika Therapeutics ... | Hague Richard | Chief Commercial Of ... | Payment of Exercise | F | 35.55 | 1,546 | 54,960 | 22,104 | 23.7 K to 22.1 K (-6.54 %) |
| Oct 25 2018 | ANIK | Anika Therapeutics ... | VOGT SUSAN L N | Director | Grant | A | 0.00 | 3,703 | 0 | 3,703 | 0 to 3.7 K |
| Sep 05 2018 | ANIK | Anika Therapeutics ... | Blanchard Cheryl R | Director | Grant | A | 0.00 | 3,624 | 0 | 3,624 | 0 to 3.6 K |
| Mar 13 2018 | ANIK | Anika Therapeutics ... | Darling Joseph G | President and CEO; ... | Payment of Exercise | F | 53.49 | 548 | 29,313 | 21,436 | 22 K to 21.4 K (-2.49 %) |
| Mar 13 2018 | ANIK | Anika Therapeutics ... | Darling Joseph G | President and CEO; ... | Grant | A | 0.00 | 7,478 | 0 | 21,984 | 14.5 K to 22 K (+51.55 %) |
| Mar 02 2018 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 50.13 | 7,788 | 390,412 | 7,788 | |
| Mar 02 2018 | ANIK | Anika Therapeutics ... | Hague Richard | Chief Commercial Of ... | Option Exercise | A | 50.13 | 7,788 | 390,412 | 7,788 | |
| Mar 02 2018 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | CEO and Director | Option Exercise | A | 50.13 | 27,984 | 1,402,838 | 27,984 | |
| Jan 26 2018 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Grant | A | 0.00 | 1,626 | 0 | 34,594 | 33 K to 34.6 K (+4.93 %) |
| Jan 26 2018 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | J | 0.00 | 1,158 | 0 | 32,968 | 34.1 K to 33 K (-3.39 %) |
| Jan 26 2018 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Sell | J | 0.00 | 1,955 | 0 | 34,126 | 36.1 K to 34.1 K (-5.42 %) |
| Jan 26 2018 | ANIK | Anika Therapeutics ... | Thompson Jeffery S | Director | Grant | A | 0.00 | 1,626 | 0 | 7,843 | 6.2 K to 7.8 K (+26.15 %) |
| Jan 26 2018 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | CEO and Director | Grant | A | 0.00 | 57,100 | 0 | 189,891 | 132.8 K to 189.9 K (+43.00 %) |
| Jan 26 2018 | ANIK | Anika Therapeutics ... | Larsen Glenn R. | Director | Grant | A | 0.00 | 1,626 | 0 | 8,103 | 6.5 K to 8.1 K (+25.10 %) |
| Jan 26 2018 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Grant | A | 0.00 | 1,626 | 0 | 15,150 | 13.5 K to 15.2 K (+12.02 %) |
| Jan 26 2018 | ANIK | Anika Therapeutics ... | Finnerty Thomas | Chief Human Resourc ... | Option Exercise | A | 61.47 | 6,700 | 411,849 | 6,700 | |
| Jan 26 2018 | ANIK | Anika Therapeutics ... | Darling Joseph G | President | Option Exercise | A | 61.47 | 21,400 | 1,315,458 | 21,400 | |
| Jan 26 2018 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 61.47 | 21,400 | 1,315,458 | 21,400 | |
| Jan 26 2018 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Grant | A | 0.00 | 1,626 | 0 | 41,162 | 39.5 K to 41.2 K (+4.11 %) |
| Jan 26 2018 | ANIK | Anika Therapeutics ... | Ahn Edward S. | Chief Tech & Strate ... | Option Exercise | A | 61.47 | 13,400 | 823,698 | 13,400 | |
| Dec 01 2017 | ANIK | Anika Therapeutics ... | Hague Richard | Chief Commercial Of ... | Sell | S | 54.48 | 5,250 | 286,020 | 23,650 | 28.9 K to 23.7 K (-18.17 %) |
| Nov 01 2017 | ANIK | Anika Therapeutics ... | Finnerty Thomas | Chief Human Resourc ... | Option Exercise | A | 54.09 | 17,000 | 919,530 | 17,000 | |
| Nov 01 2017 | ANIK | Anika Therapeutics ... | Finnerty Thomas | Chief Human Resourc ... | Grant | A | 0.00 | 6,800 | 0 | 6,800 | 0 to 6.8 K |
| Oct 26 2017 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | CEO and Director | Sell | S | 60.04 | 3,278 | 196,811 | 132,791 | 136.1 K to 132.8 K (-2.41 %) |
| Oct 24 2017 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | CEO and Director | Sell | S | 60.06 | 22,228 | 1,335,014 | 136,069 | 158.3 K to 136.1 K (-14.04 %) |
| Oct 24 2017 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | CEO and Director | Sell | S | 60.04 | 5,991 | 359,700 | 158,297 | 164.3 K to 158.3 K (-3.65 %) |
| Oct 18 2017 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | CEO and Director | Sell | S | 60.04 | 3,293 | 197,712 | 0 | 3.3 K to 0 (-100.00 %) |
| Oct 16 2017 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | CEO and Director | Sell | S | 60.11 | 5,216 | 313,534 | 167,581 | 172.8 K to 167.6 K (-3.02 %) |
| Oct 16 2017 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | CEO and Director | Sell | S | 60.00 | 1,908 | 114,480 | 172,797 | 174.7 K to 172.8 K (-1.09 %) |
| Jul 31 2017 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | CEO and Director | Sell | S | 50.79 | 63,799 | 3,240,351 | 174,705 | 238.5 K to 174.7 K (-26.75 %) |
| Jul 31 2017 | ANIK | Anika Therapeutics ... | Darling Joseph G | President | Option Exercise | A | 51.70 | 41,609 | 2,151,185 | 41,609 | |
| Jul 31 2017 | ANIK | Anika Therapeutics ... | Darling Joseph G | President | Grant | A | 0.00 | 14,506 | 0 | 14,506 | 0 to 14.5 K |
| Jul 06 2017 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President, CEO, Dir ... | Sell | S | 50.06 | 8,236 | 412,294 | 238,504 | 246.7 K to 238.5 K (-3.34 %) |
| Jul 06 2017 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President, CEO, Dir ... | Sell | S | 50.00 | 5,965 | 298,250 | 246,740 | 252.7 K to 246.7 K (-2.36 %) |
| May 23 2017 | ANIK | Anika Therapeutics ... | Thompson Jeffery S | Director | Sell | S | 47.37 | 9,628 | 456,078 | 6,217 | 15.8 K to 6.2 K (-60.76 %) |
| May 23 2017 | ANIK | Anika Therapeutics ... | Thompson Jeffery S | Director | Sell | S | 47.58 | 1,097 | 52,195 | 15,845 | 16.9 K to 15.8 K (-6.48 %) |
| Feb 24 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | M | 6.99 | 807 | 5,641 | 0 | |
| Feb 24 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | M | 6.99 | 4,193 | 29,309 | 20,000 | |
| Feb 24 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | M | 10.99 | 5,000 | 54,950 | 0 | |
| Feb 24 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Sell | S | 49.02 | 807 | 39,559 | 37,608 | 38.4 K to 37.6 K (-2.10 %) |
| Feb 24 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Sell | S | 49.05 | 1,193 | 58,517 | 38,415 | 39.6 K to 38.4 K (-3.01 %) |
| Feb 24 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Buy | M | 6.99 | 5,000 | 34,950 | 39,608 | 34.6 K to 39.6 K (+14.45 %) |
| Feb 24 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Sell | S | 49.01 | 2,000 | 98,020 | 34,608 | 36.6 K to 34.6 K (-5.46 %) |
| Feb 24 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Payment of Exercise | F | 49.20 | 1,117 | 54,956 | 36,608 | 37.7 K to 36.6 K (-2.96 %) |
| Feb 24 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Buy | M | 10.99 | 5,000 | 54,950 | 37,725 | 32.7 K to 37.7 K (+15.28 %) |
| Jan 31 2017 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Grant | A | 0.00 | 1,994 | 0 | 36,081 | 34.1 K to 36.1 K (+5.85 %) |
| Jan 31 2017 | ANIK | Anika Therapeutics ... | Thompson Jeffery S | Director | Grant | A | 0.00 | 1,994 | 0 | 16,942 | 14.9 K to 16.9 K (+13.34 %) |
| Jan 31 2017 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President, CEO, Dir ... | Option Exercise | A | 50.13 | 125,000 | 6,266,250 | 125,000 | |
| Jan 31 2017 | ANIK | Anika Therapeutics ... | Larsen Glenn R. | Director | Grant | A | 0.00 | 1,994 | 0 | 6,477 | 4.5 K to 6.5 K (+44.48 %) |
| Jan 31 2017 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Grant | A | 0.00 | 1,994 | 0 | 16,159 | 14.2 K to 16.2 K (+14.08 %) |
| Jan 31 2017 | ANIK | Anika Therapeutics ... | Hague Richard | Chief Commercial Of ... | Option Exercise | A | 50.13 | 22,500 | 1,127,925 | 22,500 | |
| Jan 31 2017 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 50.13 | 28,500 | 1,428,705 | 28,500 | |
| Jan 31 2017 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Grant | A | 0.00 | 1,994 | 0 | 39,536 | 37.5 K to 39.5 K (+5.31 %) |
| Jan 31 2017 | ANIK | Anika Therapeutics ... | Alexander Dana M. | Chief Operations Of ... | Option Exercise | A | 50.13 | 16,875 | 845,944 | 16,875 | |
| Jan 31 2017 | ANIK | Anika Therapeutics ... | Ahn Edward S. | Chief Tech & Strate ... | Option Exercise | A | 50.13 | 22,500 | 1,127,925 | 22,500 | |
| Nov 09 2016 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Option Exercise | M | 12.36 | 1,540 | 19,034 | 0 | |
| Nov 09 2016 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Sell | S | 43.31 | 40 | 1,732 | 37,542 | 37.6 K to 37.5 K (-0.11 %) |
| Nov 09 2016 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Sell | S | 43.40 | 500 | 21,700 | 37,582 | 38.1 K to 37.6 K (-1.31 %) |
| Nov 09 2016 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Payment of Exercise | F | 44.26 | 431 | 19,076 | 38,082 | 38.5 K to 38.1 K (-1.12 %) |
| Nov 09 2016 | ANIK | Anika Therapeutics ... | BOWER JOSEPH I | Director | Buy | M | 12.36 | 1,540 | 19,034 | 38,513 | 37 K to 38.5 K (+4.17 %) |
| Nov 04 2016 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Option Exercise | M | 12.36 | 1,090 | 13,472 | 0 | |
| Nov 04 2016 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Buy | M | 12.36 | 1,090 | 13,472 | 34,087 | 33 K to 34.1 K (+3.30 %) |
| May 10 2016 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President, CEO, Dir ... | Gift | G | 0.00 | 11,350 | 0 | 252,705 | 264.1 K to 252.7 K (-4.30 %) |
| Apr 06 2016 | ANIK | Anika Therapeutics ... | Mascioli Stephen R. | Chief Medical Offic ... | Option Exercise | A | 44.54 | 40,000 | 1,781,600 | 40,000 | |
| Apr 06 2016 | ANIK | Anika Therapeutics ... | Alexander Dana M. | Chief Operations Of ... | Option Exercise | A | 44.54 | 40,000 | 1,781,600 | 40,000 | |
| Feb 29 2016 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Sell | S | 43.62 | 2,695 | 117,556 | 14,165 | 16.9 K to 14.2 K (-15.98 %) |
| Feb 26 2016 | ANIK | Anika Therapeutics ... | SHERWOOD CHARLES H | President, CEO, Dir ... | Option Exercise | A | 39.69 | 18,900 | 750,141 | 18,900 | |
| Feb 26 2016 | ANIK | Anika Therapeutics ... | Cheung Sylvia | Chief Financial Off ... | Option Exercise | A | 39.69 | 3,325 | 131,969 | 3,325 | |
| Feb 26 2016 | ANIK | Anika Therapeutics ... | Ahn Edward S. | Chief Tech & Strate ... | Option Exercise | A | 39.69 | 3,325 | 131,969 | 3,325 | |
| Feb 08 2016 | ANIK | Anika Therapeutics ... | WHEELER STEVE E | Director | Grant | A | 0.00 | 2,361 | 0 | 32,997 | 30.6 K to 33 K (+7.71 %) |
| Feb 08 2016 | ANIK | Anika Therapeutics ... | Thompson Jeffery S | Director | Grant | A | 0.00 | 2,361 | 0 | 14,948 | 12.6 K to 14.9 K (+18.76 %) |
| Feb 08 2016 | ANIK | Anika Therapeutics ... | LAND RAYMOND J | Director | Grant | A | 0.00 | 2,361 | 0 | 16,860 | 14.5 K to 16.9 K (+16.28 %) |
| Feb 08 2016 | ANIK | Anika Therapeutics ... | Hague Richard | Chief Commercial Of ... | Option Exercise | A | 38.11 | 18,300 | 697,413 | 18,300 |